No. of patients |
30 |
Age (years, mean±SD) |
62.2±12.6 |
Age at onset (years, mean±SD) |
55.1±16.2 |
Duration of disease [months, Median (IQR)] |
60 (24.0–96.0) |
Follow-up duration [months, Median (IQR)] |
42.5 (24,61.5) |
Sex (male, %) |
11 (36.7%) |
Laterality (right, %) |
12 (40.0%) |
Symptomatic site |
n (%) |
Tongue, pharynx, or larynx |
22 (73.3%) |
Auricular pain |
3 (10%) |
Beneath the angle of the lower jaw |
12 (40.0%) |
Prior carbamazepine consumption (mg, mean±SD) |
473.3±152.9 |
Preoperative numeric rating scale [0–10, Median (IQR)] |
7 (6–8) |